Abstract #1041607: Effects of Prior Injectable Somatostatin Receptor Ligand Type and Dose in Patients With Acromegaly Receiving Oral Octreotide Capsules in the Phase 3 MPOWERED Trial

Oral octreotide capsules (OOC; MYCAPSSA®) are approved in the US for treating adults with acromegaly previously responding to and tolerating injectable somatostatin receptor ligands (iSRLs). MPOWERED is a phase 3 trial assessing maintenance of response to OOC compared to iSRLs in acromegaly. Here we report outcomes in patients receiving OOC based on their prior iSRL treatment (octreotide or...